WU Song,DU Yaqin,ZHANG Ping,et al.T0901317 improves renal injury in db/db mice by activating liver X receptor α[J].J Third Mil Med Univ,2020,42(01):75-80.

T0901317激活肝X受体α改善db/db小鼠肾损伤(/HTML )




T0901317 improves renal injury in db/db mice by activating liver X receptor α
吴松杜亚琴 张萍 汪伟 陈莎莎李贵森 王莉丁涵露
WU Song DU Yaqin ZHANG Ping WANG Wei CHEN Shasha LI Guisen WANG Li DING Hanlu

Department of Nephrology, Sichuan Provincial People’s Hospital, Medical School of University of Electronic Science and Technology, Chengdu, Sichuan Province, 610072, China

db/db mice liver X receptor thrombomodulin diabetic nephropathy
R692.9; R966; R977.6

目的 观察肝X受体(liver X receptor,LXR)激动剂T0901317、血栓调节蛋白(thrombomodulin,TM)干扰RNA重组腺病毒Ad-TMshRNA对db/db糖尿病肾病(diabetic nephropathy, DN)小鼠肾损伤的影响。方法12周龄雄性db/db小鼠36只,应用随机数字表法进行分组,分为DN生理盐水组、Ad-ctrl+DN组、Ad-TM shRNA+DN组、T0901317+DN组、Ad-TMshRNA+T0901317+DN组和Ad-ctrl+T090131+DN组,每组6只小鼠。2.5×109 pfu Ad-TMshRNA和Ad-ctrl分别通过尾静脉注射到对应组小鼠,1周后T0901317按0.5 mg/(kg·d)灌胃对应组小鼠且连续给药7 d。4周后,采用 Western blot检测小鼠肾组织LXRα、LXRβ、VCAM-1和ICAM-1表达;检测血肌酐水平,同周龄雄性野生C57BL/6小鼠给予生理盐水胃饲作为正常对照组。结果DN组、Ad-ctrl+DN组较野生小鼠,其肾组织LXRα表达下降(P<0.05),与DN、Ad-ctrl+DN组和Ad-TMshRNA+DN组比较,T0901317+DN组、Ad-TMshRNA+T0901317+DN组、Ad-ctrl+T0901317+DN组小鼠肾组织LXRα表达增加(P<0.05)。DN各组小鼠LXRβ表达较野生鼠下降,T0901317对DN各组小鼠肾组织LXRβ表达无显著影响。DN组、Ad-ctrl+DN组较野生小鼠,血肌酐、肾组织VCAM-1和ICAM-1表达升高、肾组织病理损伤加重(P<0.05),与DN对照组比较,Ad-TMshRNA沉默组小鼠肾组织损伤加重、肾组织VCAM-1和ICAM-1表达增加(P<0.05),而T0901317+DN和Ad-ctrl+T0901317+DN组小鼠肾损伤减轻、VCAM-1和ICAM-1表达减少(P<0.05)。结论T0901317可能通过激活LXRα减少VCAM-1和ICAM-1表达从而改善db/db小鼠肾损伤。


ObjectiveTo determine the effects of liver X receptor (LXR) agonist T0901317 and thrombomodulin (TM) interfering RNA recombinant adenovirus Ad-TM shRNA on renal injury of db/db mice with diabetic nephropathy (DN). MethodsA total of 36 male db/db mice (12 weeks old) were randomly assigned into 6 groups (n=6), DN group, Ad-ctrl+DN group, Ad-TMshRNA+DN group, T0901317+DN group, Ad-TMshRNA+T0901317+DN group and Ad-ctrl+T0901317+DN group. PBS, 2.5×109 pfu Ad-TM shRNA and Ad-ctrl were injected into mice through tail vein to corresponding mice, while 0.5 mg/(kg·d) T0901317 was intragastrically administered to the corresponding mice for 7 consecutive days. After treatment for 4 weeks, the kidney tissues were collected for detecting the expression of LXRα, LXRβ, VCAM-1 and ICAM-1 by Western blotting. The serum creatinine level was also detected in all the mice. Male wild-type C57BL/6 mice at the same age served as normal control. ResultsThe expression of LXRα in kidney tissue was significantly lower in the DN group and Ad-ctrl+DN group than the wild-type mice (P<0.05), but was obviously higher in the T0901317+DN group, the Ad-TMshRNA+T0901317+DN group and the Ad-ctrl+T0901317+DN group than the DN group, Ad-ctrl+DN group and the Ad-TM shRNA+DN group (P<0.05). The expression of LXRβ in DN mice was notably lower than that in the wild-type mice (P<0.05). T0901317 had no significant effect on the LXRβ expression in renal tissue of DN mice. The DN control group and Ad-ctrl+DN group had significantly higher serum level of creatinine and renal expression of VCAM-1 and ICAM-1, and aggravated renal pathological damages when compared with the wild-type mice (P<0.05). When compared with the DN group, Ad-TMshRNA silenced mice groups had severer renal damages and elevated expression of VCAM-1 and ICAM-1 (P<0.05), while the renal damages were alleviated and the expression of VCAM-1 and ICAM-1 were decreased in the T0901317+DN group and the Ad-ctrl+T0901317+DN group (P<0.05). ConclusionT0901317 improves renal injury in db/db mice by activating LXRα to reduce the expression of VCAM-1 and ICAM-1.


[1]KARIMI Z, KAHE F, JAMIL A, et al. Intercellular adhesion molecule-1 in diabetic patients with and without microalbuminuria[J]. Diabetes Metab Syndr, 2018, 12(3): 365-368. DOI:10.1016/j.dsx.2017.12.028.
[2]HELLEMONS M E, KERSCHBAUM J, BAKKER S J, et al. Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review[J]. Diabet Med, 2012, 29(5): 567-577. DOI:10.1111/j.1464-5491.2011.03437.x.
[3]NAVARRO-GONZLEZ J F, MORA-FERNNDEZ C, MUROS DE FUENTES M, et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy[J]. Nat Rev Nephrol, 2011, 7(6): 327-340. DOI:10.1038/nrneph.2011.51.
[4]DROZ·DZ· D, ATKA M, DROZ·DZ· T, et al. Thrombomodulin as a new marker of endothelial dysfunction in chronic kidney disease in children[J]. Oxid Med Cell Longev, 2018, 2018: 1619293. DOI:10.1155/2018/1619293.
[5]MATSUMOTO K, YANO Y, GABAZZA E C, et al. Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients[J]. Diabet Med, 2007, 24(12): 1322-1328. DOI:10.1111/j.1464-5491.2007.02289.x.
[6]LI F L, YANG N S, ZHANG L L, et al. Increased expression of Toll-like receptor 2 in rat diabetic nephropathy[J]. Am J Nephrol, 2010, 32(2): 179-186. DOI:10.1159/000317023.
[7]PALOMER X, GONZLEZ-CLEMENTE J M, BLANCO-VACA F, et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus[J]. Diabetes Obes Metab, 2008, 10(3): 185-197. DOI:10.1111/j.1463-1326.2007.00710.x.
[8]HIEN H T M, HA N C, THOM L T, et al. Squalene promotes cholesterol homeostasis in macrophage and hepatocyte cells via activation of liver X receptor (LXR) α and Β[J]. Biotechnol Lett, 2017, 39(8): 1101-1107. DOI:10.1007/s10529-017-2345-y.
[9]FESSLER M B. The challenges and promise of targeting the liver X receptors for treatment of inflammatory disease[J]. Pharmacol Ther, 2018, 181: 1-12. DOI:10.1016/j.pharmthera.2017.07.010.
[10]DING H L, LI Y, FENG Y L, et al. LXR agonist T0901317 upregulates thrombomodulin expression in glomerular endothelial cells by inhibition of nuclear factor-κB[J]. Mol Med Rep, 2016, 13(6): 4888-4896. DOI:10.3892/mmr.2016.5138.
[11]SHANKLAND S J, SCHOLEY J W, LY H, et al. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy[J]. Kidney Int, 1994, 46(2): 430-442. DOI:10.1038/ki.1994.291.
[12]AUSTIN H A 3rd, MUENZ L R, JOYCE K M, et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome[J]. Kidney Int, 1984, 25(4): 689-695. DOI:10.1038/ki.1984.75.
[13]YANG C C, ZHOU C J, LI J, et al. Quantitative proteomic study of the plasma reveals acute phase response and LXR/RXR and FXR/RXR activation in the chronic unpredictable mild stress mouse model of depression[J]. Mol Med Rep, 2018, 17(1): 93-102. DOI:10.3892/mmr.2017.7855.
[14]ENDO-UMEDA K, NAKASHIMA H, UMEDA N, et al. Dysregulation of kupffer cells/macrophages and natural killer T cells in steatohepatitis in LXRα knockout male mice[J]. Endocrinology, 2018, 159(3): 1419-1432. DOI:10.1210/en.2017-03141.
[15]ISERMANN B, VINNIKOV I A, MADHUSUDHAN T, et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis[J]. Nat Med, 2007, 13(11): 1349-1358. DOI:10.1038/nm1667.
[16]TACHIBANA S, IYODA M, MATSUMOTO K, et al. Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar-Kyoto rats through anti-inflammatory effects[J]. Nephrol Dial Transplant, 2019, 34(5): 774-782. DOI:10.1093/ndt/gfy201.
[17]OZAKI T, ANAS C, MARUYAMA S, et al. Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure[J]. Nephrol Dial Transplant, 2008, 23(1): 110-119. DOI:10.1093/ndt/gfm563.


 CHENG Jun,LI Jin-ping,TIAN Zhuo,et al.Effects of liver X receptor agonist on the expressions of C-reactive protein and CD40 ligand and contents of smooth muscle cells in the aorta of ApoE gene knockout mice[J].J Third Mil Med Univ,2009,31(01):1281.
 Yu Huihong,Shen Wei,Guo Jinjun.Dynamic expression of acetylated histone in transcription regulation area of fatty acid synthase related to liver X receptor[J].J Third Mil Med Univ,2012,34(01):54.
 Wang Qiang,Yu Jie,Wang Hang,et al.Liver X receptors agonist T0901317 promotes human umbilical vein endothelial cell proliferation via activation of PI3K/Akt pathway[J].J Third Mil Med Univ,2012,34(01):481.

更新日期/Last Update: 2020-01-07